Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Treatment – Beyond the Abstract
high-grade non-muscle-invasive bladder cancer (HGNMIBC), non-muscle-invasive bladder cancer (NMIBC), NCT02324582, BCG therapy, post-BCG treatment, phase I dose-escalation trial.